Nurix Therapeutics, Inc. (NRIX)
26.93
+0.66
(+2.51%)
USD |
NASDAQ |
Aug 25, 13:27
Nurix Therapeutics Price to Book Value : 6.936 for Aug. 25, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 24, 2026 | 6.766 |
| August 21, 2026 | 6.882 |
| August 20, 2026 | 6.967 |
| August 19, 2026 | 7.158 |
| August 18, 2026 | 6.936 |
| August 17, 2026 | 6.998 |
| August 14, 2026 | 6.967 |
| August 13, 2026 | 7.003 |
| August 12, 2026 | 6.859 |
| August 11, 2026 | 6.686 |
| August 10, 2026 | 6.666 |
| August 07, 2026 | 6.576 |
| August 06, 2026 | 6.496 |
| August 05, 2026 | 6.47 |
| August 04, 2026 | 6.359 |
| August 03, 2026 | 5.981 |
| July 31, 2026 | 5.978 |
| July 30, 2026 | 6.073 |
| July 29, 2026 | 6.078 |
| July 28, 2026 | 6.220 |
| July 27, 2026 | 6.035 |
| July 24, 2026 | 6.022 |
| July 23, 2026 | 6.114 |
| July 22, 2026 | 6.078 |
| July 21, 2026 | 6.048 |
| Date | Value |
|---|---|
| July 20, 2026 | 5.849 |
| July 17, 2026 | 5.955 |
| July 16, 2026 | 5.942 |
| July 15, 2026 | 6.143 |
| July 14, 2026 | 5.919 |
| July 13, 2026 | 5.849 |
| July 10, 2026 | 5.939 |
| July 09, 2026 | 6.359 |
| July 08, 2026 | 6.261 |
| July 07, 2026 | 6.284 |
| July 06, 2026 | 6.192 |
| July 02, 2026 | 6.174 |
| July 01, 2026 | 6.158 |
| June 30, 2026 | 6.248 |
| June 29, 2026 | 6.143 |
| June 26, 2026 | 5.898 |
| June 25, 2026 | 5.785 |
| June 24, 2026 | 4.971 |
| June 23, 2026 | 4.858 |
| June 22, 2026 | 4.804 |
| June 18, 2026 | 4.520 |
| June 17, 2026 | 4.410 |
| June 16, 2026 | 4.397 |
| June 15, 2026 | 4.389 |
| June 12, 2026 | 4.366 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Monte Rosa Therapeutics, Inc. | 2.531 |
| Gilead Sciences, Inc. | 15.50 |
| TG Therapeutics, Inc. | 14.19 |
| Cue Biopharma, Inc. | 62.14 |
| Keros Therapeutics, Inc. | 0.8692 |
Price to Book Value Related Metrics
| PS Ratio | 73.32 |
| PEG Ratio | -0.2442 |
| Price | 26.93 |
| Earnings Yield | -12.80% |
| Market Cap | 2.793B |
| PEGY Ratio | -0.2442 |